Options to purchase securities from registrant or subsidiaries
(a) At 31 January 2008, options outstanding to subscribe for Ordinary Shares of $0.25 of the Company were:
| Number of shares | Subscription price | Normal expiry date |
|---|---|---|
| 46,514,629 | 1913p-3487p | 2008-2017 |
The weighted average subscription price of options outstanding at 31 January 2008 was 2702p. All options were granted under Company employee share schemes.
(b) Included in paragraph (a) are options granted to Directors and Officers of AstraZeneca as follows:
| Number of shares | Subscription price | Normal expiry date |
|---|---|---|
| 1,925,548 | 2132p-3487p | 2008-2017 |
(c) Included in paragraph (b) are options granted to individually named Directors. Details of these option holdings at 31 December 2007 are shown in the Directors’ Remuneration Report.
During the period 1 January 2008 to 31 January 2008, John Patterson exercised options over 625 Ordinary Shares under the AstraZeneca Savings-Related Share Option Scheme and retained all the shares so acquired.
